1. Home
  2. LGND vs TR Comparison

LGND vs TR Comparison

Compare LGND & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • TR
  • Stock Information
  • Founded
  • LGND 1987
  • TR 1896
  • Country
  • LGND United States
  • TR United States
  • Employees
  • LGND 68
  • TR N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • TR Specialty Foods
  • Sector
  • LGND Health Care
  • TR Consumer Staples
  • Exchange
  • LGND Nasdaq
  • TR Nasdaq
  • Market Cap
  • LGND 3.2B
  • TR 2.9B
  • IPO Year
  • LGND 1992
  • TR N/A
  • Fundamental
  • Price
  • LGND $169.53
  • TR $41.06
  • Analyst Decision
  • LGND Strong Buy
  • TR
  • Analyst Count
  • LGND 8
  • TR 0
  • Target Price
  • LGND $144.71
  • TR N/A
  • AVG Volume (30 Days)
  • LGND 139.7K
  • TR 163.1K
  • Earning Date
  • LGND 08-05-2025
  • TR 10-23-2025
  • Dividend Yield
  • LGND N/A
  • TR 0.86%
  • EPS Growth
  • LGND N/A
  • TR N/A
  • EPS
  • LGND N/A
  • TR 1.24
  • Revenue
  • LGND $181,488,000.00
  • TR $722,849,000.00
  • Revenue This Year
  • LGND $18.41
  • TR N/A
  • Revenue Next Year
  • LGND $18.87
  • TR N/A
  • P/E Ratio
  • LGND N/A
  • TR $33.18
  • Revenue Growth
  • LGND 53.40
  • TR N/A
  • 52 Week Low
  • LGND $81.74
  • TR $28.18
  • 52 Week High
  • LGND $129.90
  • TR $41.94
  • Technical
  • Relative Strength Index (RSI)
  • LGND 72.58
  • TR 57.27
  • Support Level
  • LGND $161.82
  • TR $39.23
  • Resistance Level
  • LGND $169.00
  • TR $41.94
  • Average True Range (ATR)
  • LGND 3.90
  • TR 1.03
  • MACD
  • LGND -0.81
  • TR -0.03
  • Stochastic Oscillator
  • LGND 98.73
  • TR 59.76

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About TR Tootsie Roll Industries Inc.

Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.

Share on Social Networks: